I am afraid it doesn't stack up that way. From my understanding the two dogs mentioned in the announcement commenced in October 2014, no date for when the third dog commenced treatment. Why if the first two dogs started in October 2014 they can not release data on these two dogs.
The object of Directors is to increase the value to shareholders and currently this is not happening.
Pharma section up 19% in the last twelve months, PAA down from .019 in March this year to current level of .009 so more then a 50% drop so the market doesnt see added value, or is there a dilution due to additional shares to be issued to Morris and Ashton on positive results being taken into account.
Ann: Change of Director's Interest Notice, page-76
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |